Personalis has announced the issuance of a key US Patent related to its industry-leading minimal residual disease (MRD) and recurrence platform, NeXT Personal.

Program participants receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers and biotin.

AMSBIO has introduced further essential tools for SARS-CoV-2 researchers to help decipher the COVID-19 B.1.1.529 variant.

Element Biosciences Inc. has announced the commercial launch of the Element AVITI™ System, a benchtop sequencer offering an unrivaled combination of performance, cost and flexibility.

Olink Holding has announced its collaboration with TATAA Biocenter, launching Olink®Explore 3072 proteome profiling service.

SPT Labtech has announced the launch of firefly®, an innovative liquid handling platform for next-generation sequencing library preparation.

Paperpal Preflight leverages AI and machine learning to support authors and journal editors during manuscript submission process.

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products.

This complete next generation sequencing solution will allow laboratories to increase sequencing throughput and make reliable variant identifications.

Eppendorf SE has donated 20,000 euros to the European Molecular Biology Laboratory (EMBL) during an online presentation ceremony. The funds are for the EMBL project “Advancement of Women in Science,” which enables women scientists to begin managerial careers in scientific fields.